Domestic pharmaceutical industry is at risk

Amid the domestic pharmaceutical industry's concerns over the repeated cuts in insurance drug prices following the government ex post facto drug management, the new reimbursement price re-evaluation system aiming at reducing the current drug prices will be implemented from this December, thus it is likely to hit the hardest blow to the domestic pharmaceutical industry.

Although the Ministry...